zepbound or tirzepatide Now Available Through LillyDirect: A New Option for Access at a Predictable Price Zepbound® (Tirzepatide) | Mochi Health

This law regulates and recognizes accreditation for public healthcare facilities, ensuring they are licensed and operated correctly

* Food Supplements should not be used as a substitute for a variedand balanced dietand healthy lifestyle

Participants were asked whether they had used medication in the past year to manage type 2 diabetes (excluding insulin), reduce the risk of heart disease, or support weight loss and, if so, whether they had used any of five specific GLP-1 or dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists

This is so much more than just a new way to fill a prescription

Additionally, tirzepatide, a dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist, was approved in May 2022 for adults with T2DM (Mounjaro , Eli Lilly and Company) and in November 2023 for chronic weight management (Zepbound , Eli Lilly and Company) [11, 12]